K050029

Substantially Equivalent

CARDIOMPO TEST

Applicant: Prognostix, Inc.
Product code: NTV
Advisory panel: Immunology
Date received: 2005-01-06
Decision date: 2005-05-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cleveland, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.